Campbell Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Campbell Wealth Management's LLY Position: Q4 2024 in Review
Campbell Wealth Management increased its Eli Lilly (LLY) stake by 672% in Q4 2024, buying an estimated $1.78M and bringing the position to 2,470 shares worth $1.91M. The position accounts for 0.17% of the portfolio, ranked #22.
Campbell Wealth Management first reported a position in LLY in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.92M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Campbell Wealth Management held 2,470 shares of Eli Lilly worth $1.91M as of Q4 2024.
- Campbell Wealth Management bought 2,150 Eli Lilly shares in Q4 2024, an estimated $1.78M.
- Eli Lilly made up 0.17% of Campbell Wealth Management's portfolio in Q4 2024, its #22 holding.
- Campbell Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 12 quarters since.
- Campbell Wealth Management's Eli Lilly position peaked at $1.92M in Q1 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Campbell Wealth Management's 13F filing for Q4 2024, filed 30 Jan 2025.